Related Experiment Video
Updated: Mar 9, 2026

05:54
MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor
Published on: December 13, 2017
15.0K
Re-emergent tremor in Parkinson's disease
Daniele Belvisi1, Antonella Conte2, Matteo Bologna2
1Neuromed Institute IRCCS, Via Atinense 18, 86077, Pozzilli (IS), Italy.
Parkinsonism & Related Disorders
|December 24, 2016
Summary
Re-emergent tremor (RET) in Parkinson's disease (PD) is a benign subtype. Patients with RET show less severe motor symptoms compared to those without RET, suggesting a distinct, milder clinical presentation.
Area of Science:
- Neurology
- Movement Disorders
- Parkinson's Disease Research
Background:
- Re-emergent tremor (RET) is a specific type of postural tremor observed in Parkinson's disease (PD) patients.
- RET emerges after a delay and its clinical characteristics require further investigation.
Purpose of the Study:
- To determine the prevalence of RET in a Parkinson's disease cohort.
- To characterize the clinical features of RET, including latency, severity, and affected body side.
- To explore associations between RET and other motor/non-motor symptoms in PD.
Main Methods:
- Consecutive assessment of 210 Parkinson's disease patients.
- Collection of demographic and clinical data, including RET characteristics.
- Comparative analysis of clinical features between patients with and without RET.
Main Results:
- RET was identified in 42 out of 210 patients (20%).
- Mean RET latency was 9.2 seconds, with a mean severity of 2.4; 21 patients had unilateral RET.
- Patients with RET exhibited less severe bradykinesia, postural, and gait disturbances compared to those without RET.
Conclusions:
- RET may represent a benign subtype of Parkinson's disease, potentially similar to isolated resting tremor.
- Action tremor, whether isolated or combined with resting tremor, may indicate a distinct and more severe PD subtype.
- RET is associated with a milder clinical phenotype within the tremor-dominant Parkinson's disease group.
Related Concept Videos
Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Neural Regulation
43.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.9K
REM Sleep Behavior Disorder
2.2K
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
2.2K
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Brainstem
7.5K
The brainstem, located inferior to the brain and superior to the spinal cord, serves as a bridge between the cerebrum and the spinal cord. It plays a vital role in relaying information and controlling critical life functions. It comprises three primary regions: the midbrain, pons, and medulla oblongata.
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...
7.5K

